ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS

  • Authors:
    • V SCHIRRMACHER
    • A GRIESBACH
    • V UMANSKY
    • M ROCHA
  • View Affiliations

  • Published online on: August 1, 1994     https://doi.org/10.3892/ijo.5.2.141
  • Pages: 141-151
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We describe the generation and immunotherapeutic properties of syngeneic immune T cells activated in situ against the lymphoma variant ESb which metastasizes to multiple organs (liver, lung, spleen, bone) and can develop sophisticated immune escape mechanisms. Peritoneal effector cells (PEC) generated from intra-pinna tumor immunized and i.p. restimulated mice were able to transfer protective immunity in the absence of exogenous cytokines into normal or 5Gy irradiated or SCID mice which had been injected either s.c. or i.v. with 5x10(3) to 10(5) metastatic ESb tumor cells. Protective immunity was specific for ESb cells and could be followed by growth retardation of s.c. tumors as well as by prevention or retardation of death from metastases. Expression of protective immunity was independent of host T cells since it was similarly expressed in SCID-mice and sublethally irradiated mice. Preincubation in vitro for 24 h of the PEC before adoptive transfer led to pronounced decrease of protective immunity while the tumor specific cytotoxic T lymphocyte (CTL) activity was maintained or even enhanced. These results demonstrate i) that protective immunity in vivo requires more than tumor specific cytotoxic activity and ii) that in vitro culture of immune cells can change their in vivo functional properties.

Related Articles

Journal Cover

August 1994
Volume 5 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
SCHIRRMACHER V, GRIESBACH A, UMANSKY V and ROCHA M: ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS. Int J Oncol 5: 141-151, 1994
APA
SCHIRRMACHER, V., GRIESBACH, A., UMANSKY, V., & ROCHA, M. (1994). ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS. International Journal of Oncology, 5, 141-151. https://doi.org/10.3892/ijo.5.2.141
MLA
SCHIRRMACHER, V., GRIESBACH, A., UMANSKY, V., ROCHA, M."ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS". International Journal of Oncology 5.2 (1994): 141-151.
Chicago
SCHIRRMACHER, V., GRIESBACH, A., UMANSKY, V., ROCHA, M."ADOPTIVE TRANSFER OF PROTECTIVE IMMUNITY AGAINST A HIGH METASTATIC TUMOR-CELL VARIANT BY SMALL NUMBERS OF TUMOR-SPECIFIC IN-SITU ACTIVATED PERITONEAL EFFECTOR T-CELLS". International Journal of Oncology 5, no. 2 (1994): 141-151. https://doi.org/10.3892/ijo.5.2.141